DE602004031744D1 - Kristallisation von festen formen von clopidogreladditionssalzen - Google Patents

Kristallisation von festen formen von clopidogreladditionssalzen

Info

Publication number
DE602004031744D1
DE602004031744D1 DE602004031744T DE602004031744T DE602004031744D1 DE 602004031744 D1 DE602004031744 D1 DE 602004031744D1 DE 602004031744 T DE602004031744 T DE 602004031744T DE 602004031744 T DE602004031744 T DE 602004031744T DE 602004031744 D1 DE602004031744 D1 DE 602004031744D1
Authority
DE
Germany
Prior art keywords
clopidogreladditional
crystallization
salts
solid forms
clopidogrel
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602004031744T
Other languages
English (en)
Inventor
Berta Kotar-Jordan
Igor Simonic
Rok Zupet
Milos Ruzic
Marija Grcman
Anica Pecavar
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
KRKA dd
Original Assignee
KRKA Tovarna Zdravil dd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by KRKA Tovarna Zdravil dd filed Critical KRKA Tovarna Zdravil dd
Publication of DE602004031744D1 publication Critical patent/DE602004031744D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Glass Compositions (AREA)
  • Liquid Crystal Substances (AREA)
  • Cephalosporin Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DE602004031744T 2003-08-13 2004-08-11 Kristallisation von festen formen von clopidogreladditionssalzen Active DE602004031744D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10337773A DE10337773A1 (de) 2003-08-13 2003-08-13 Kristallisation von festen Formen von Clopidogrel-Additionssalzen
PCT/EP2004/008989 WO2005016931A2 (en) 2003-08-13 2004-08-11 Crystallisation of solid forms of clopidogrel addition salts

Publications (1)

Publication Number Publication Date
DE602004031744D1 true DE602004031744D1 (de) 2011-04-21

Family

ID=34177655

Family Applications (2)

Application Number Title Priority Date Filing Date
DE10337773A Withdrawn DE10337773A1 (de) 2003-08-13 2003-08-13 Kristallisation von festen Formen von Clopidogrel-Additionssalzen
DE602004031744T Active DE602004031744D1 (de) 2003-08-13 2004-08-11 Kristallisation von festen formen von clopidogreladditionssalzen

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DE10337773A Withdrawn DE10337773A1 (de) 2003-08-13 2003-08-13 Kristallisation von festen Formen von Clopidogrel-Additionssalzen

Country Status (9)

Country Link
EP (1) EP1656381B1 (de)
AT (1) ATE501153T1 (de)
DE (2) DE10337773A1 (de)
ES (1) ES2362660T3 (de)
HR (1) HRP20110418T1 (de)
PL (1) PL1656381T3 (de)
PT (1) PT1656381E (de)
SI (1) SI1656381T1 (de)
WO (1) WO2005016931A2 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI1740593T1 (sl) * 2004-04-19 2016-08-31 Krka, Tovarna Zdravil, D.D., Novo Mesto Postopek za pripravo polimorfne oblike I klopidogrel hidrogen sulfata
EP1693375A1 (de) * 2005-02-21 2006-08-23 KRKA, tovarna zdravil, d.d., Novo mesto Verfahren zur Herstellung von Clopidrogel hydrogen sulfat in Form I
CA2655844A1 (en) * 2006-08-03 2008-02-14 Teva Pharmaceutical Industries Ltd. Process for preparing clopidogrel bisulphate
SI22383A (sl) * 2006-09-22 2008-04-30 Krka, Tovarna Zdravil, D.D., Novo Mesto Nov postopek sinteze klopidogrela in nove oblike njegovih farmacevtsko sprejemljivih soli
KR101378596B1 (ko) 2006-12-27 2014-03-26 경동제약 주식회사 결정성 클로피도그렐 · 황산염 형태 ｉ의 제조방법
PL382055A1 (pl) * 2007-03-23 2008-09-29 Koźluk Tomasz Nobilus Ent Sposób wytwarzania formy krystalicznej 1 wodorosiarczanu klopidogrelu
EP2107061A1 (de) 2008-04-02 2009-10-07 Krka Tovarna Zdravil, D.D., Novo Mesto Herstellungsverfahren für optisch angereichertes Clopidogrel
AU2009264395B2 (en) * 2008-06-24 2013-12-05 Zach System S.P.A. Process for the preparation of clopidogrel hydrogen sulfate crystalline form I
WO2011010318A1 (en) * 2009-07-23 2011-01-27 Praveen Laboratories Private Limited Process for the preparation of clopidogrel polymorphous form 1 using seed chrystals
WO2011042804A2 (en) 2009-10-08 2011-04-14 Jubliant Life Sciences Limited An improved process for the preparation of clopidogrel hydrogen sulfate form i
CN102358743A (zh) * 2011-11-05 2012-02-22 江南大学 一种制备无定形氯吡格雷硫酸氢盐的简便方法
CN102432625A (zh) * 2011-11-05 2012-05-02 江南大学 一种制备高纯度i型氯吡格雷硫酸氢盐的结晶方法
CN103044444B (zh) * 2013-01-21 2015-04-15 上海现代哈森（商丘）药业有限公司 一种高纯度ⅰ型(+)-(s)-硫酸氢氯吡格雷的合成方法
CN103923100B (zh) * 2014-04-03 2019-05-14 浙江华海药业股份有限公司 一种硫酸氢氯吡格雷的精制方法
CN104478895B (zh) * 2014-12-05 2017-04-12 广东东阳光药业有限公司 氯吡格雷硫酸盐的制备方法
CN107118221B (zh) * 2017-05-24 2021-09-07 常州制药厂有限公司 一种硫酸氢氯吡格雷晶型i制备方法
CN107163060B (zh) * 2017-05-24 2021-03-02 常州制药厂有限公司 一种硫酸氢氯吡格雷晶型ii制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2530247B1 (fr) * 1982-07-13 1986-05-16 Sanofi Sa Nouveaux derives de la thieno (3, 2-c) pyridine, leur procede de preparation et leur application therapeutique
FR2623810B2 (fr) * 1987-02-17 1992-01-24 Sanofi Sa Sels de l'alpha-(tetrahydro-4,5,6,7 thieno(3,2-c) pyridyl-5) (chloro-2 phenyl) -acetate de methyle dextrogyre et compositions pharmaceutiques en contenant
FR2779726B1 (fr) * 1998-06-15 2001-05-18 Sanofi Sa Forme polymorphe de l'hydrogenosulfate de clopidogrel
AU2002320286A1 (en) * 2001-07-02 2003-01-21 Thomas W. Wilson Method and system for analyzing resource allocation
KR100839136B1 (ko) * 2001-12-18 2008-06-20 테바 파마슈티컬 인더스트리즈 리미티드 클로피도그렐 황산수소염의 다형
CZ297472B6 (cs) * 2002-08-27 2006-12-13 Zentiva, A.S. Zpusob výroby clopidogrelu hydrogensulfátu krystalické formy I
WO2004048385A2 (en) * 2002-11-28 2004-06-10 Instytut Farmaceutyczny A process for the preparation of crystalline form 1 or clopidogrel hydrogen sulfate
WO2004081016A1 (en) * 2003-03-12 2004-09-23 Cadila Healthcare Limited Polymorphs and amorphous form of (s) - (+) -clopidogrel bisulfate

Also Published As

Publication number Publication date
PT1656381E (pt) 2011-06-16
EP1656381B1 (de) 2011-03-09
ATE501153T1 (de) 2011-03-15
WO2005016931A2 (en) 2005-02-24
ES2362660T3 (es) 2011-07-11
HRP20110418T1 (hr) 2011-06-30
SI1656381T1 (sl) 2011-07-29
EP1656381A2 (de) 2006-05-17
WO2005016931A3 (en) 2005-04-28
DE10337773A1 (de) 2005-03-24
PL1656381T3 (pl) 2011-08-31

Similar Documents

Publication Publication Date Title
ATE501153T1 (de) Kristallisation von festen formen von clopidogreladditionssalzen
DE602004013405D1 (de) Polymorphe formen von valsartan
DE60230327D1 (de) Polymorphe von clopidogrel-hydrogensulfat
HUP0300731A2 (hu) Valzartan-sók, eljárás elżállításukra és az azokat tartalmazó gyógyszerkészítmények
HK1112238A1 (en) Substituted benzo(d)isoxazol-3-yl amine compounds as analgesics
ATE444746T1 (de) Eine herstellungsmethode von entacapon- enthaltenden granulaten für orale dosierformen
ATE431337T1 (de) Kristallisation und aufreinigung von glykopyrroniumbromid
CY1105994T1 (el) Aναδιαταγμενες πεντανολες, μεθοδος για την παραγωγη αυτων και η χρηση αυτων ως αντιφλεγμονωδων
ATE489365T1 (de) Verfahren und zwischenprodukte zur herstellung von (1r,2s,5s)-6,6-dimethyl-3-azabicycloä3,1,0 ühexan-2-carboxylaten oder salzen davon
MEP15908A (en) 1-amino-2-oxy-substituted tetrahydronaphtalene derivatives, methods for the production thereof, and their use as antiphlogistics
EP1672077A4 (de) Verfahren zur herstellung von bernsteinsäure
BG111461A (en) TECHNICAL METHOD FOR OBTAINING TROPENOL
CY1108808T1 (el) Ενωσεις μοτιλιδης
CY1109740T1 (el) Νεα μεθοδος συνθεσης παραγωγων της 1,3,4,5 -τετραϋδρο-2η- 3-βενζαζεπιν-2-ονης και εφαρμογη στη συνθεση της ιβαβραδινης και των αλατων προσθηκης της σε ενα φαρμακευτικως αποδεκτο οξυ
MY147404A (en) Process for preparation of n-benzoyl-staurosporine
EA200700146A1 (ru) Кристаллизированный полиэтилентерефталат, содержащий кремний, и способ его получения
UA94080C2 (ru) Ациклически-замещенные производные фуропиримидина и их применение для лечения сердечно-сосудистых заболеваний
EA200700807A1 (ru) Новые циклические и ациклические пропеноны для лечения заболеваний цнс
DE60224592D1 (de) Polymorph und andere kristallinische Formen von Zusammen-FTC
ZA200800138B (en) Process for the preparation of crystalline perindopril
UA106580C2 (uk) Фармацевтично прийнятні солі тимодепресину і спосіб їх виробництва
GB2422842B (en) Process for the production of multipurpose energy sources and multipurpose energy sources produced by said process
EA200201101A1 (ru) Соингибиторы для получения очищенного насыщенного солевого раствора
ATE403418T1 (de) Verfahren zur herstellung von festen dosierformen von amorphem valganciclovir-hydrochlorid
BR0214971A (pt) Processo para a produção de um imunossupressor